Literature DB >> 14670300

CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection.

Vanja Lazarevic1, Amy J Myers, Charles A Scanga, JoAnne L Flynn.   

Abstract

CD40(-/-) mice succumbed to low-dose aerosol infection with M. tuberculosis due to deficient IL-12 production leading to impaired priming of IFN-gamma T cell responses. In contrast, CD40L(-/-) mice were resistant to M. tuberculosis. This asymmetry in outcome of infection between the two knockout strains is likely due to the existence of an alternative ligand for CD40. Both in vitro M. tuberculosis infection and recombinant M. tuberculosis Hsp70 elicited IL-12 production from WT dendritic cells. This response was absent in both CD40(-/-) dendritic cells and CD40(-/-) mice, suggesting that M. tuberculosis Hsp70 serves as an alternative ligand for CD40 in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670300     DOI: 10.1016/s1074-7613(03)00324-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  37 in total

1.  Early events in Mycobacterium tuberculosis infection in cynomolgus macaques.

Authors:  Philana Ling Lin; Santosh Pawar; Amy Myers; Amarenda Pegu; Carl Fuhrman; Todd A Reinhart; Saverio V Capuano; Edwin Klein; Joanne L Flynn
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Tumour necrosis factor-alpha production stimulated by heat shock protein 70 and its inhibition in circulating dendritic cells and cells eluted from mucosal tissues in Crohn's disease.

Authors:  T Whittall; Y Wang; C G Kelly; R Thompson; J Sanderson; M Lomer; S Y Soon; L A Bergmeier; M Singh; T Lehner
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

3.  A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

Authors:  Denise Kirschner; Elsje Pienaar; Simeone Marino; Jennifer J Linderman
Journal:  Curr Opin Syst Biol       Date:  2017-05-22

4.  CD40 in Endothelial Cells Restricts Neural Tissue Invasion by Toxoplasma gondii.

Authors:  Jose-Andres C Portillo; Jennifer Van Grol; Saad Saffo; Yalitza Lopez Corcino; Myriam Rodriguez; Barbara A Fox; David J Bzik; Nicole L Ward; George R Dubyak; Roxana E Rojas; Zahra Toosi; Carlos S Subauste
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes.

Authors:  William W Reiley; Mark D Calayag; Susan T Wittmer; Jennifer L Huntington; John E Pearl; Jeffrey J Fountain; Cynthia A Martino; Alan D Roberts; Andrea M Cooper; Gary M Winslow; David L Woodland
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

Review 6.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

7.  Interleukin-12 therapy reduces the number of immune cells and pathology in lungs of mice infected with Mycobacterium tuberculosis.

Authors:  Dawn Nolt; JoAnne L Flynn
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

9.  CD40 ligand and interferon-γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes.

Authors:  Georgiana M Klug-Micu; Steffen Stenger; Andrea Sommer; Philip T Liu; Stephan R Krutzik; Robert L Modlin; Mario Fabri
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

10.  Impaired immune responses in the lungs of aged mice following influenza infection.

Authors:  Franklin R Toapanta; Ted M Ross
Journal:  Respir Res       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.